Testing effectiveness (Phase 2)Study completedNCT00048321
What this trial is testing
ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis
Who this might be right for
Rheumatoid Arthritis
Ionis Pharmaceuticals, Inc. 160